OMOP Concept 37557193
Cabozantinib, Ipilimumab, Nivolumab
StandardRegimenHemOnc112559Regimen
Maps from
0
Descendants
0
Valid from
24 Mar 2023
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(40)Roll up to these when you need a wider cohort.
- 1Anti-CTLA-4 antibody-containing regimen
- 1Anti-PD-1 antibody-containing regimen
- 1cabozantinib
- 1Cabozantinib-containing regimen
- 1ICI-containing regimen
- 1Immunotherapy
- 1Immunotherapy-containing regimen
- 1ipilimumab
- 1Ipilimumab-containing regimen
- 1Multiagent regimen
- 1nivolumab
- 1Nivolumab-containing regimen
- 1Targeted therapy
- 1Targeted therapy-containing regimen
- 1VEGFR inhibitor-containing regimen
- 2Anti-CTLA-4 antibody
- 2Anti-LAG-3 antibody
- 2Anti-PD-1 antibody
- 2AXL inhibitor
- 2Combination drug
- 2FLT3 inhibitor
- 2Generic class-based regimen
- 2KIT inhibitor
- 2MET inhibitor
- 2Named class-based regimen
Get this concept via the API
Resolve Cabozantinib, Ipilimumab, Nivolumab - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37557193?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card